Huanyu Chen

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

Zev A. Wainberg, Davide Melisi, Teresa Macarulla et al. · The Lancet · 2023 · 439 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements

Dickran Kazandjian, Gideon M. Blumenthal, Huanyu Chen et al. · The Oncologist · 2014 · 289 citations · Full text

Medicine, Oncology, Pharmacology +12

Associations of Increases in Serum Creatinine with Mortality and Length of Hospital Stay after Coronary Angiography

Steven D. Weisbord, Huanyu Chen, Roslyn A. Stone et al. · Journal of the American Society of Nephrology · 2006 · 231 citations

Medicine, Cardiology, Internal Medicine +16

FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1

Lola A. Fashoyin‐Aje, Martha Donoghue, Huanyu Chen et al. · The Oncologist · 2018 · 227 citations · Full text

Medicine, Oncology, Pharmacology +17

Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis

Julia A. Beaver, Maitreyee Hazarika, Flora Mulkey et al. · The Lancet Oncology · 2018 · 177 citations · Full text

Medicine, Dermatology, Oncology +17